0

530207

BRAWN

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

BRAWN BIOTECH LTD. Share Price Today

Investment Returns

Over 1 Month 8.54% Over 3 Months 4.04% Over 6 Months 4.04% Over 1 Year 28.52%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

BRAWN BIOTECH LTD. fundamentals


  • Market cap (Cr) [-]
  • P/E Ratio (TTM) [-]
  • Beta [-]
  • Book Value / share [-]
  • Return on equity [-]%
  • EPS (TTM) [-]
  • Dividend yield [-]%
  • Net profit/quarter (Cr) [-]
info icon alternate text
  • Market cap (Cr) 6.60
  • P/E Ratio (TTM) 6.96
  • Beta -0.18
  • Book Value / share 14.46
  • Return on equity -41.33%
  • EPS (TTM) 3.14
  • Dividend yield [-]%
  • Net profit/quarter (Cr) 0.58
info icon alternate text

BRAWN BIOTECH LTD. Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition
info-icon
Revenue
Net income
Particulars MAR 2026 (Values in Cr)
Revenue 1.98
Operating Expense 2.51
Net Profit 0.58
Net Profit Margin (%) 29.29
Earnings Per Share (EPS) 1.95
EBITDA -0.32
Effective Tax Rate (%) 261.11
Particulars DEC 2025 (Values in Cr)
Revenue 4.31
Operating Expense 4.35
Net Profit 0.05
Net Profit Margin (%) 1.16
Earnings Per Share (EPS) 0.17
EBITDA 0.08
Effective Tax Rate (%) 0.00
Particulars SEP 2025 (Values in Cr)
Revenue 4.89
Operating Expense 4.91
Net Profit 0.07
Net Profit Margin (%) 1.43
Earnings Per Share (EPS) 0.25
EBITDA 0.10
Effective Tax Rate (%) 0.00
Particulars JUN 2025 (Values in Cr)
Revenue 5.80
Operating Expense 5.65
Net Profit 0.24
Net Profit Margin (%) 4.13
Earnings Per Share (EPS) 0.89
EBITDA 0.27
Effective Tax Rate (%) 0.00
Particulars MAR 2025 (Values in Cr)
Revenue 2.26
Operating Expense 2.84
Net Profit -0.49
Net Profit Margin (%) -21.68
Earnings Per Share (EPS) -1.65
EBITDA -0.45
Effective Tax Rate (%) 0.00
Particulars MAR 2026 (Values in Cr)
Revenue 16.98
Operating Expense 17.43
Net Profit 0.94
Net Profit Margin (%) 5.53
Earnings Per Share (EPS) 3.26
EBITDA 0.12
Effective Tax Rate (%) 0.00
Particulars MAR 2025 (Values in Cr)
Revenue 13.47
Operating Expense 15.35
Net Profit -1.80
Net Profit Margin (%) -13.36
Earnings Per Share (EPS) -5.87
EBITDA -1.69
Effective Tax Rate (%) 0.00
Particulars MAR 2024 (Values in Cr)
Revenue 16.49
Operating Expense 18.12
Net Profit -1.54
Net Profit Margin (%) -9.33
Earnings Per Share (EPS) -5.14
EBITDA -1.44
Effective Tax Rate (%) 0.00
Particulars MAR 2023 (Values in Cr)
Revenue 22.23
Operating Expense 22.65
Net Profit -0.87
Net Profit Margin (%) -3.91
Earnings Per Share (EPS) -3.04
EBITDA -0.29
Effective Tax Rate (%) -112.19
Particulars MAR 2022 (Values in Cr)
Revenue 8.62
Operating Expense 10.74
Net Profit -1.64
Net Profit Margin (%) -19.02
Earnings Per Share (EPS) -5.25
EBITDA -2.01
Effective Tax Rate (%) 22.16
Particulars MAR 2025 (Values in Cr)
Book Value / Share 11.21
ROE % -41.33
ROCE % -18.71
Total Debt to Total Equity 0.00
EBITDA Margin -12.48
Particulars MAR 2024 (Values in Cr)
Book Value / Share 16.88
ROE % -21.99
ROCE % -20.47
Total Debt to Total Equity 0.00
EBITDA Margin -8.37
Particulars MAR 2023 (Values in Cr)
Book Value / Share 21.03
ROE % -12.86
ROCE % -5.74
Total Debt to Total Equity 0.00
EBITDA Margin -1.30
Particulars MAR 2022 (Values in Cr)
Book Value / Share 24.07
ROE % -20.49
ROCE % -24.95
Total Debt to Total Equity 0.00
EBITDA Margin -23.20
Particulars MAR 2021 (Values in Cr)
Book Value / Share 29.31
ROE % -6.09
ROCE % -3.49
Total Debt to Total Equity 0.00
EBITDA Margin -0.83
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 0.19
Total Assets 20.48
Total Liabilities 20.48
Total Equity 3.36
Share Outstanding 0
Price to Book Ratio 1.45
Return on Assets (%) -8.49
Return on Capital (%) -51.75
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 0.39
Total Assets 14.58
Total Liabilities 14.58
Total Equity 5.06
Share Outstanding 0
Price to Book Ratio 1.18
Return on Assets (%) -8.54
Return on Capital (%) -24.62
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.43
Total Assets 14.53
Total Liabilities 14.53
Total Equity 6.30
Share Outstanding 0
Price to Book Ratio 0.79
Return on Assets (%) -5.97
Return on Capital (%) -13.76
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 0.22
Total Assets 13.78
Total Liabilities 13.78
Total Equity 7.22
Share Outstanding 0
Price to Book Ratio 0.72
Return on Assets (%) -11.92
Return on Capital (%) -22.77
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.39
Total Assets 13.87
Total Liabilities 13.87
Total Equity 8.79
Share Outstanding 0
Price to Book Ratio 0.75
Return on Assets (%) -3.96
Return on Capital (%) -6.26
Particulars MAR 2025 (Values in Cr)
Net Income -1.79
Cash from Operations 0.04
Cash from Investing -0.24
Cash from Financing 0.00
Net change in Cash -0.19
Free Cash Flow 0.28
Particulars MAR 2024 (Values in Cr)
Net Income -1.54
Cash from Operations -0.02
Cash from Investing -0.01
Cash from Financing 0.00
Net change in Cash -0.04
Free Cash Flow -0.01
Particulars MAR 2023 (Values in Cr)
Net Income -0.41
Cash from Operations 0.30
Cash from Investing -0.09
Cash from Financing 0.00
Net change in Cash 0.21
Free Cash Flow 0.40
Particulars MAR 2022 (Values in Cr)
Net Income -2.11
Cash from Operations 0.18
Cash from Investing -0.29
Cash from Financing -0.06
Net change in Cash -0.17
Free Cash Flow 0.48
Particulars MAR 2021 (Values in Cr)
Net Income -0.35
Cash from Operations 0.30
Cash from Investing 0.00
Cash from Financing -0.03
Net change in Cash 0.00
Free Cash Flow 0.30
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENT L 31.36 12.96 1.51 240.32 23.12 38.85
BLISS GVS PHARMA LTD 459.75 37.32 4.08 4875.93 118.35 493.70
CIPLA LTD. 1437.35 30.50 3.37 116115.65 1165.55 1672.20
FERMENTA BIOTECH LTD. 365.20 16.11 2.64 1074.82 256.40 399.00
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENT L 31.36 21.93 4.04 240.32 23.12 38.85
AMRUTAJAN HEALTH LTD 535.55 24.00 4.18 1548.31 490.00 789.95
ASTRAZENECA PHARMA INDIA LTD. 8465.25 110.56 24.24 21163.13 7630.00 9850.00
BLISS GVS PHARMA LTD 459.75 49.60 4.22 4875.93 118.35 493.70

BRAWN BIOTECH LTD. shareholding pattern

Holding
46.71%
52.94%
0.34%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

BRAWN BIOTECH LTD. Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
21.85 4.04 redarrow
red-green-graph indicator
4 Bearish
12 Bullish
  • 5 Days 21.10
  • 26 Days 20.50
  • 10 Days 20.70
  • 50 Days 20.50
  • 12 Days 20.60
  • 100 Days 20.50
  • 20 Days 20.50
  • 200 Days 20.40
21.24 PIVOT
First Support 20.62 First Resistance 22.46 Second Support 19.40 Second Resistance 23.08 Third Support 18.78 Third Resistance 24.30
RSI 58.14 ADX 18.24 MACD 0.09 Williams % R 0.00 Commodity Channel Index (CCI) 60.65
Date 2026-06-24 Week 949.00 Same Day 1000.00 Month 564.00
1 Year -0.18 3 Year 0.05
Over 1 Month
8.54% down
Over 1 Year
28.52% down
Over 3 Months
4.04% down
Over 3 Years
13.84% down
Over 6 Months
4.04% down
Over 5 Years
1.78% down

BRAWN BIOTECH LTD. Corporate Actions

Dividend date Dividend amount Dividend type Record date Instrument type
12 Sep 2018 1.0 Final 15 Sep 2018 Equity shares
14 Sep 2017 1.5 Final 16 Sep 2017 Equity shares

Top Gainers

Top Losers

stock
Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Brawn Biotech Ltd?

Answer Field

Brawn Biotech Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 21.85 as on Jun 25 2026 03:15 PM.

What is the Market Cap of Brawn Biotech Ltd Share?

Answer Field

The market cap of Brawn Biotech Ltd for NSE ₹ 0.00 & for BSE ₹ 6.60 as on Jun 25 2026 03:15 PM.

What is the 52 Week High and Low of Brawn Biotech Ltd?

Answer Field

The 52 Week High and Low of Brawn Biotech Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 24.37 and ₹ 16.16.

What is 1 year return for Brawn Biotech Ltd?

Answer Field

The 1 year returns on the stock has been 28.52%.

What is the P/E Ratio of Brawn Biotech Ltd Share?

Answer Field

As on Jun 25 2026 03:15 PM the price-to-earnings (PE) ratio for Brawn Biotech Ltd share is 6.96.

What is the PB ratio of Brawn Biotech Ltd Share?

Answer Field

As on Jun 25 2026 03:15 PM, the price-to-book (PB) ratio for Brawn Biotech Ltd share is 14.46.

How to Buy Brawn Biotech Ltd Share?

Answer Field

You can trade in Brawn Biotech Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Brawn Biotech Ltd Share on Bajaj Broking App?

Answer Field

To buy Brawn Biotech Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Brawn Biotech Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image
Get Free Demat Account*
+91
close-img
Authorise with OTP
Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59
banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|